AstraZeneca's Imjudo finally snags first approval—only in an ever-crowded liver cancer field – FiercePharma October 25, 2022 by Andrew Anthony AstraZeneca’s Imjudo finally snags first approval—only in an ever-crowded liver cancer field FiercePharmasource
